Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Incyte Corp (INCY)  
$53.22 0.21 (0.39%) as of 4:30 Tue 4/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 219,000,000
Market Cap: 11.66(B)
Last Volume: 1,465,374 Avg Vol: 1,578,590
52 Week Range: $52.16 - $75.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  144
Guru Rank Value     : 7.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 9,299 39,259 138,275
Total Sell Value $0 $603,781 $2,515,280 $10,787,547
Total People Sold 0 3 4 7
Total Sell Transactions 0 4 6 15
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 1551
  Page 1 of 63  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Harrigan Edmund Director   –       •      –    2024-03-28 4 A $56.97 $23,529 D/D 413 13,115     -
   Clancy Paul J Director   –       •      –    2024-03-28 4 A $56.97 $22,959 D/D 403 15,785     -
   Baker Julian   –       •       •   2024-03-28 4 A $0.00 $0 I/I 1,086 33,447,981     -
   Trotta Matteo EVP, GM, Dermatology US   •       –      –    2024-03-25 4 A $0.00 $0 D/D 7,828 7,828     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2024-02-14 4 A $0.00 $0 D/D 7,377 97,595     -
   Swain Paula J EVP, Human Resources   •       –      –    2024-02-14 4 A $0.00 $0 D/D 7,377 84,907     -
   Hoppenot Herve Chairman / CEOPresident   •       •      –    2024-02-14 4 A $0.00 $0 D/D 41,577 502,333     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2024-02-14 4 A $0.00 $0 D/D 7,377 89,983     -
   Iyengar Vijay K EVP, GMAPPS   •       –      –    2024-02-14 4 A $0.00 $0 D/D 7,377 50,789     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2024-02-14 4 A $0.00 $0 D/D 7,377 85,080     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2024-02-12 4 D $57.84 $22,384 D/D (387) 82,606     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2024-01-22 4 D $61.50 $6,642 D/D (108) 72,300     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2024-01-22 4 D $61.50 $6,642 D/D (108) 44,380     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2024-01-19 4 D $61.49 $7,502 D/D (122) 44,488     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2024-01-19 4 D $61.49 $7,502 D/D (122) 72,408     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2024-01-18 4 A $61.18 $496,415 D/D 8,114 44,610     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2024-01-18 4 A $61.18 $694,944 D/D 11,359 72,530     -
   Tray Thomas Principal Accounting Officer   •       –      –    2024-01-17 4 D $61.48 $62,771 D/D (1,021) 22,415     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2024-01-17 4 D $61.48 $225,939 D/D (3,675) 77,703     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2024-01-17 4 D $61.48 $6,209 D/D (101) 36,496     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2024-01-17 4 D $61.48 $6,209 D/D (101) 61,171     -
   Dickinson Jonathan Elliott EVP, General Manager, Europe   •       –      –    2024-01-16 4 D $61.34 $6,195 D/D (101) 36,597     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2024-01-16 4 D $61.34 $6,195 D/D (101) 61,272     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2024-01-03 4 S $65.51 $482,481 D/D (7,365) 90,218 19%     
   Iyengar Vijay K EVP, GMAPPS   •       –      –    2024-01-02 4 S $65.00 $42,705 D/D (657) 43,412 19%     
  1551 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 63
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us